Roth Capital Reaffirms 'Buy' Rating for PolyPid (NASDAQ: PYPD) Amidst Strategic Partnership
| Show full article |
|
This functionality is available for registred users only
|
-
Full namePolyPid Ltd.
-
Registration countryIsrael
-
IndustryMedical Devices
-
М/S&P/F
*** /*** /***









